You're signed outSign in or to get full access.
General Catalyst Group Management, LLC
General Catalyst Group Management, LLC is a Cambridge, Massachusetts-based venture capital and investment firm founded in 2000. The firm specializes in early-stage and growth-stage investments, primarily serving technology and healthcare startups, and manages approximately $4.3 billion in assets. General Catalyst employs a team of highly experienced professionals and supports founders through various stages of company growth by providing capital, operational support, and strategic guidance.
Investment Strategy
General Catalyst Group Management focuses on partnering with breakthrough technology and healthcare companies, investing in their early and growth stages. Its strategy is to back founders who are building resilient, category-defining enterprises; the firm leverages its deep sector expertise and operational resources to accelerate growth and drive long-term value. General Catalyst typically concentrates its portfolio on a select group of high-potential ventures, actively supporting innovation that shapes the future across diverse industries.
Latest 13F Filing Activity
General Catalyst Group Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 10 equity positions with a total 13F market value of $4B. The fund increased holdings in Circle Internet Group Inc., Oscar Health Inc., Fractyl Health Inc. among other positions. General Catalyst Group Management, LLC reduced exposure to Samsara Inc., Snowflake, Inc., Evolv Techology Holdings, Inc. among others.
Top Holdings
Equity Positions (10)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CRCL | CIRCLE INTERNET GROUP INC | 84.87% | $3.65B | 20,120,769 | $181.29 | $181.29 | +$3.65B |
I IOT | SAMSARA INC | 11.09% | $476.6M | 11,981,331 | $28.11 | $39.78 | -$191.9M |
O OSCR | OSCAR HEALTH INC | 1.05% | $45.2M | 2,107,719 | $26.88 | $21.44 | +$17.6M |
G GTLB | GITLAB INC | 0.97% | $41.6M | 921,405 | $87.00 | $45.11 | -$1.7M |
A AVBP | ARRIVENT BIOPHARMA INC | 0.76% | $32.5M | 1,494,786 | $18.31 | $21.77 | +$4.9M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more